DRIO News Alert Labstyle Innovations Corp. (DRIO) 0.1240 12/26/2014

New Post Public Reply Private Reply Replies (0) Message Board

Dec 26, 2014 at 4:53 AM

Labstyle Innovations Corp. (DRIO) 0.1240 $DRIO

LabStyle Innovations Awarded Reimbursement Status in Australia for the Dario(TM) Smart Meter Strips
PR Newswire - Wed Dec 03, 8:05AM CST
LabStyle Innovations Corp. (OTCQB: DRIO) the maker of the Dario(TM) smart meter for diabetics announced today that it has been granted reimbursement status for its Dario(TM) blood glucose test strips to be utilized together with the patented Dario(TM) smart meter in Australia. This achievement marks another milestone in the continuing worldwide roll out of Dario(TM).

LabStyle Innovations Announces Two Board Appointments
PR Newswire - Mon Nov 24, 8:05AM CST
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today announced that Dr. Peter Kash and Ms. Hila Karah have been appointed to serve on the company's Board of Directors.

LabStyle Innovations Announces 2014 Third Quarter Results and Provides Business Update
PR Newswire - Fri Nov 14, 8:15AM CST
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today reported its financial and operational results for the three month period ending September 30, 2014 and provided an update on recent corporate achievements and anticipated milestones for the remainder of 2014 and 2015.

LabStyle Innovations Common Stock to Resume Trading Under the Symbol "DRIO"
PR Newswire - Wed Nov 05, 8:15AM CST
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today announced that its common stock will resume trading on the OTCQB Market under the symbol "DRIO."

LabStyle Innovations implements one for five reverse stock split
M2 - Mon Oct 06, 7:20AM CDT
Diabetes management solution LabStyle Innovations (Other OTC

RIO) reported on Monday the launch of a one-for-five reverse common stock split at 9:00 eastern standard time.

LabStyle Innovations Implements 1-for-5 Reverse Stock Split
PR Newswire - Mon Oct 06, 5:00AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today announced that effective at 9:00 a.m. eastern standard time on October 6, 2014, the company will implement a 1-for-5 reverse stock split of the company's common stock.

LabStyle Innovations Closes $4.2 Million Non-Brokered Private Placement Financing
PR Newswire - Tue Sep 23, 3:05PM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today announced that it has closed a $4.2 million private placement offering consisting of shares of preferred stock and warrants. No placement agent was used for this financing. After estimated offering expenses, LabStyle expects to secure net proceeds of approximately $4.1 million from this financing.

OTC Daily Trading News: Evoq Properties, Inc. MedBox, Inc. LabStyle Innovations Corp, MyEcheck, Inc. Elite Pharmaceuticals, Inc.
PR Newswire Europe - Tue Aug 19, 10:11AM CDT
LONDON, August 19, 2014 /PRNewswire/ --

LabStyle Innovations Reports 2014 Second Quarter Results and Anticipated Milestones for the Remainder of the Year
PR Newswire - Fri Aug 15, 8:05AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today reported its financial and operational results for the three and six months period ending June 30, 2014. The company also presented an overview of results of the Dario(TM) smart meter soft launch, recent corporate achievements and anticipated milestones for the remainder of 2014.

LabStyle Innovations Announces the Initial Launch of the Dario(TM) Diabetes Management Solution for Android Devices
PR Newswire - Thu Jul 31, 8:50AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, announced today that the company has released the Dario(TM) Diabetes Management App for Android smartphone users. The mobile application will have the same user interface and features as the iOS Dario(TM) Application and will be available in select soft launch markets, including the United Kingdom and New Zealand.

LabStyle Innovations wins Israeli Ministry of Health's approval to market the Dario Smart Meter to people living with diabetes in Israel
M2 - Tue Jul 29, 6:09AM CDT
Diabetes management company LabStyle Innovations (Other OTC

RIO) disclosed on Monday the receipt of the Israeli AMAR's approval for the marketing and sale of the Dario Smart Meter in Israel.

LabStyle Innovations Receives Israeli Ministry of Health Approval for the Dario(TM) Smart Meter
PR Newswire - Mon Jul 28, 8:05AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, announced today that it has received approval from the Israeli AMAR for the marketing and sale of the Dario(TM) Smart Meter in Israel. The Israeli AMAR is a unit in the Ministry of Health and is responsible for certification of all activities concerning medical devices import, sale and export and is a precondition for the sale of medical devices in Israel.

LabStyle Innovations Corp.'s CEO Erez Raphael Interviewed by The Life Sciences Report
Marketwire - Thu Jul 17, 8:25AM CDT
Having a chronic disease like diabetes engenders a sense of isolation that hasn't been adequately addressed by technology until now. With Dario, LabStyle Innovations Corp. (OTCQB: DRIO) has created a device that not only provides vital medical information to a diabetic patient in real time, but also connects that patient to a community of care providers, family, and online resources. In this interview with The Life Sciences Report, LabStyle President and CEO Erez Raphael describes how the Dario software platform could provide sufferers of other chronic diseases with the benefits of real-time data and community as well.

LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors
PR Newswire - Thu Jul 10, 11:00AM CDT
LabStyle Innovations Corp. (OTCQB

RIO), developer of the Dario(TM) Diabetes Management Solution, today announced the appointment of Professor Richard B. Stone as an independent member of its Board of Directors.

LabStyle Innovations to distribute its Dario Smart Meter, test strips and lancets in the Netherlands through Viper Medical
M2 - Thu Jul 10, 7:35AM CDT
LabStyle Innovations (OTCQB

RIO), a mobile health company that provides laboratory-testing products, reported on Wednesday the launch of an exclusive distribution agreement for its Dario Smart Meter, test strips and lancets in the Netherlands through Viper Medical.

LabStyle Innovations to Commence Sales of Dario(TM) in the Netherlands
PR Newswire - Wed Jul 09, 8:05AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, announced today that the company is increasing its market reach by entering into an agreement with Viper Medical for exclusive distribution of the Dario(TM) Smart Meter, test strips and lancets in the Netherlands.

Falling Earnings Estimates Signal Weakness Ahead for Hansen Medical (HNSN) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jul 01, 7:35AM CDT
Hansen Medical one such stock considered to drop as it has witnessed a significant price decline and has seen negative earnings
MASI: 26.60 (+0.04), HNSN: 0.55 (-0.02)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PathoSearch: A New Era in Pathology With Visual Search

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Damp or Dry: The Battle for Healthy Air in Colorado

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Delhi Pushes Innovation Against Dryland Challenges

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Larry Ellison's Moves Signal Confidence in Oracle's Future

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

PureHealth's Acid Reflux Solutions: An Investor's Insight

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Countries Eye New Investment Paths at CIFIT 2026

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

ARTiSTORY's Strategic Advance in Cultural IP Licensing

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

IASLC Boosts Global Thoracic Cancer Collaboration

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...